Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver Nanoparticles and XP-Endo Finisher in Necrotic Mandibular Molars
NCT06771570Completed
- Start
- Aug 2022
- Primary completion
- Aug 2024
- Modality
- Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised trial of silver nanoparticles in pulp necrosis and apical periodontitis (AP). Primary endpoint: Postoperative Pain at 4 days. Started Aug 2022; status: completed.
02
Drugs
silver nanoparticles
03
Conditions
pulp necrosisapical periodontitis (AP)
Beyond the preview
Go deeper on NCT06771570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06771570.